• UCLA Health
  • myUCLAhealth
  • School of Medicine
Office of Compliance Services

Office of Compliance Services

Office of Compliance Services
  • About Our Program
    • Message from the Vice Chancellor
    • Code of Conduct & Statement of Ethics
    • Organizational Structure
    • Contact Us
    • Staff Spotlight
    • Program Description
    • Hotline Information
    • Conflict of Interest/Vendor Relations
    • Other Informative Sites
  • Compliance Services
    • Clinical Research Billing
    • Hospital Compliance
    • Professional Compliance
    • Frequently Asked Questions
    • EMTALA Compliance Program
  • Information Security & Privacy
    • Device Security
    • Additional Resources
    • HIPAA Training
    • Forms
    • Guidance and Policies
    • Frequently Asked Questions
  • Education & Training
    • Clinical Research Compliance Training
    • New and Current Faculty Training
    • EMTALA Training
    • HIPAA Training
    • Ethics Briefing/Conflict of Interest Training
    • Clinical Laboratory and Pathology Compliance Training
    • Advisory Notices
    • Webinars
  • Policies & Procedures
    • Clinical Laboratory and Pathology Compliance
    • Ronald Reagan UCLA Medical Center (Westwood)
    • Resnick Neuropsychiatric Hospital at UCLA
    • UCLA Santa Monica Medical Center
  • Compliance Tips
    • Frequently Asked Questions
    • Information Security Tips
    • Privacy Tips
    • Hospital, Physician, and Clinical Research Tips
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

Office of Compliance Services

Frequently Asked Questions

  1. Home
  2. Frequently Asked Questions

Frequently Asked Questions

Share this

Is there FDA guidance concerning retention of Electronic Case Report Forms (eCRFs) ?

Yes, in November 2012, FDA released a new draft guidance entitled “Electronic Source Data in Clinical Investigations”. Based on this document, the clinical investigator should retain control of the records (i.e., completed and signed eCRF or certified copy of the eCRF). If requested, the clinical investigator should provide FDA with access to the records that serve as the electronic source data. When data elements are transcribed from paper sources into an eCRF, the clinical investigator(s) must also retain the paper sources, or certified copies.

Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Compliance Hotline
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth